| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.28B | 20.58B | 20.93B | 25.07B | 32.54B | 20.52B |
| Gross Profit | 1.31B | 4.52B | 8.16B | 9.35B | 9.15B | 5.16B |
| EBITDA | 1.08B | 5.42B | 5.42B | 3.49B | 5.40B | 3.60B |
| Net Income | 2.33B | 2.11B | 1.89B | 742.00M | 2.54B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 39.74B | 37.48B | 37.34B | 41.28B | 49.96B | 39.97B |
| Cash, Cash Equivalents and Short-Term Investments | 2.08B | 263.00M | 1.81B | 2.11B | 7.14B | 1.58B |
| Total Debt | 11.57B | 10.89B | 10.49B | 13.73B | 18.49B | 10.38B |
| Total Liabilities | 30.09B | 27.87B | 28.29B | 34.08B | 44.20B | 34.42B |
| Stockholders Equity | 8.57B | 8.52B | 8.11B | 7.02B | 5.56B | 5.38B |
Cash Flow | ||||||
| Free Cash Flow | 2.14B | 2.21B | 1.72B | 2.41B | -460.00M | 539.00M |
| Operating Cash Flow | 4.03B | 4.05B | 3.57B | 4.70B | 1.67B | 2.62B |
| Investing Cash Flow | -2.87B | -2.71B | -1.33B | 3.20B | -8.16B | -3.07B |
| Financing Cash Flow | -1.03B | -1.99B | -3.50B | -6.66B | 6.65B | 752.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $184.66B | 22.23 | 15.24% | 2.84% | 11.51% | 47.33% | |
70 Outperform | $71.60B | 20.32 | 11.86% | 3.25% | 9.38% | 31.12% | |
67 Neutral | $43.34B | 12.98 | 27.50% | 4.06% | 6.40% | 18.01% | |
66 Neutral | $106.59B | 20.00 | 12.28% | 3.40% | 8.33% | -6.26% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | $97.97B | 16.43 | 9.85% | 3.61% | 7.21% | 8.97% | |
61 Neutral | $27.33B | 15.88 | 8.32% | 3.13% | 7.52% | 21.81% |